https://scholars.lib.ntu.edu.tw/handle/123456789/197926
標題: | 行政院國家科學委員會專題研究計畫成果報告:台灣多發性硬化症患者之臨床分析及生活品質 | 作者: | 楊智超 | 公開日期: | 2002 | 出版社: | 臺北市:國立臺灣大學醫學院神經科 | 摘要: | Multiple sclerosis (MS) has a lower prevalence rate in Orientals than in Caucasians. The Japanese are by far the best studied of the non-Caucasoid populations. In Chinese, there have been reports from Hong Kong, mainland China, and Taiwan. From Taiwan, Hung et al.(1976) described 25 patients, including two autopsied patients. Tsai et al. reported 43 cases from Veterans General Hospital, Taipei in 2002. In this report, clinical findings of 100 patients in Taiwan with definite MS according to Poser’s criteria and positive findings on magnetic resonance imaging have been reviewed. The aim of this report is to highlight the clinical course and pattern of presentation in the largest sample of cases managed so far in Taiwan. During the past 10 years there have been unprecedented advances in the development of new disease-modifying therapies for multiple sclerosis (MS). The emergence of interferon-ß and glatiramer acetate that appear to alter the natural history of MS is encouraging. These agents were introduced to Taiwan in recent years. We also present our preliminary results of interferon –ß treatment in patients with relapsing-remitting MS. |
URI: | http://ntur.lib.ntu.edu.tw//handle/246246/26087 | 其他識別: | 902314B002245 | Rights: | 國立臺灣大學醫學院神經科 |
顯示於: | 醫學系 |
檔案 | 描述 | 大小 | 格式 | |
---|---|---|---|---|
902314B002245.pdf | 101.78 kB | Adobe PDF | 檢視/開啟 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。